Core A, the Administrative Core, will continue to provide organizational support for the leadership of theSPORE, facilitate communication among the component activities of the SPORE, serve as the home forpancreatic cancer SPORE advocate activities, and provide an organizational portal for collaborationsoutside the SPORE. Core A's functions are to: 1) Provide leadership and coordination between theResearch Projects and Cores of the SPORE; 2) Assure ongoing integration and participation of thePancreatic Cancer SPORE in the activities of Mayo Clinic Cancer Center; 3) Organize monthly meetingsof the SPORE investigators; 4) Organize yearly research retreats and meetings of the External AdvisoryCommittee; 5) Organize meetings of the SPORE Scientific Advisory Committee as needed; 6) Organizemonthly meetings of the SPORE Steering Committee; 7) Provide administrative support to theDevelopmental Research Program; 8) Provide administrative support to the Career DevelopmentProgram; 9) Facilitate investigator trips to the annual SPORE meetings in the mid-Atlantic region; 10)Facilitate activities of the pancreatic cancer SPORE advocates; 11) Prepare the yearly non-competingSPORE application; 12) Serve as the administrative liaison between the Mayo Clinic SPORE and the NCISPORE Program, other SPOREs, and collateral resources, such as PACGENE, PANC4, PanCAN, thePhase II Consortium, and the North Central Cancer Treatment Group; 13) Maintain the Mayo PancreaticCancer SPORE websites that will be useful to investigators inside and outside the SPORE, as well aspatients; 14) Coordinate information and communication about SPORE-related research developments toand among the Mayo Clinic SPORE investigators, to the scientific community at large, and to the public.The Core leader, Dr. Petersen, will continue to direct Core A in close consultation with the SteeringCommittee so that maximum potential for translational objectives can continue to be achieved.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA102701-06
Application #
7510969
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Project Start
2008-07-01
Project End
2013-06-30
Budget Start
2008-07-01
Budget End
2009-08-31
Support Year
6
Fiscal Year
2008
Total Cost
$122,388
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Orozco, Carlos A; Martinez-Bosch, Neus; Guerrero, Pedro E et al. (2018) Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. Proc Natl Acad Sci U S A 115:E3769-E3778
Radecki Breitkopf, Carmen; Wolf, Susan M; Chaffee, Kari G et al. (2018) Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners. J Empir Res Hum Res Ethics 13:295-304
Antwi, Samuel O; Fagan, Sarah E; Chaffee, Kari G et al. (2018) Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status. J Natl Cancer Inst :
Cobo, Isidoro; Martinelli, Paola; Flández, Marta et al. (2018) Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas. Nature 554:533-537
Razidlo, Gina L; Burton, Kevin M; McNiven, Mark A (2018) Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42. J Biol Chem 293:11143-11153
Chaker, Mahmoud; Minden, Audrey; Chen, Suzie et al. (2018) Rho GTPase effectors and NAD metabolism in cancer immune suppression. Expert Opin Ther Targets 22:9-17
Sugimoto, Motokazu; Farnell, Michael B; Nagorney, David M et al. (2018) Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg 22:831-839
Danai, Laura V; Babic, Ana; Rosenthal, Michael H et al. (2018) Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558:600-604
Paradise, Brooke D; Barham, Whitney; Fernandez-Zapico, Martín E (2018) Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes? Cancers (Basel) 10:
Hogan, Kelly A; Cho, Dong Seong; Arneson, Paige C et al. (2018) Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment. Cytokine 107:9-17

Showing the most recent 10 out of 336 publications